Thermo Fisher $11.5 billion acquisition of QIAGEN

3/3/2020
Public acquisition

$ 11.5 billion

Announced

3/3/2020


Overview:

  • Global life sciences and laboratory applications company Thermo Fisher Scientific has made a public offer to acquire QIAGEN, a German sample preparations technology provider, in an $11.5 billion transaction. 
  • QIAGEN is headquartered in the Netherlands, despite main operations taking place in Germany and is listed on both the Frankfurt and New York stock exchanges. 
  • The takeover is expected to be completed in 2021.

Natasha Forrest - Researcher

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in